Hak-Hyun Nam
Founder bij I-SENS, INC.
Vermogen: 31 M $ op 31-03-2024
Profiel
Hak-Hyun Nam is the founder of i-SENS, Inc. which was founded in 2000.
She is currently a Non-Executive Director at Precision Biosensor, Inc., a Director at I Sense Jiangsu Co., Ltd., and a Director at CoaguSense, Inc. Dr. Nam holds a doctorate degree from Michigan State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
I-SENS, INC.
7.21% | 15-04-2024 | 1 985 000 ( 7.21% ) | 30 M $ | 31-03-2024 |
| 30-06-2023 | 100 000 ( 0.86% ) | 362 488 $ | 31-03-2024 |
Actieve functies van Hak-Hyun Nam
| Bedrijven | Functie | Begin |
|---|---|---|
| I-SENS, INC. | Founder | 04-05-2000 |
| PRECISION BIOSENSOR, INC. | Director/Board Member | - |
| I Sense Jiangsu Co., Ltd. | Director/Board Member | - |
CoaguSense, Inc.
 CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Director/Board Member | - |
Opleiding van Hak-Hyun Nam
| Michigan State University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| I-SENS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Precision Biosensor, Inc. | |
| I Sense Jiangsu Co., Ltd. | |
CoaguSense, Inc.
CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Electronic Technology |
